Description
Cytarzer 1000mg
Composition: Cytarabine 1000mg BP /10 ml
Classification: Anticancer Medicine
Cytarzer: Proven and Trusted Treatment for Leukemia
Cytarzer, widely prescribed by oncologists, offers an affordable treatment for various blood cancers, especially AML. The anticancer medicines manufactured by Aprazer are globally trusted for their premium quality and safety standards. WHO-GMP certified, assured therapeutic efficacy and safety.
What is Cytarzer?
Cytarzer is an anticancer medicine used for different types of lymphoma and leukemia.
Uses of Cytarzer
- • Advanced stage Acute Myeloid Leukemia (AML)
- • Leukemia of the meninges
- • Lymphocytic / Nonlymphocytic leukemia
- • Refractory leukemia
How does Cytarzer work?
It inhibits DNA replication, multiplication, and the formation of new cancer cells.
Common Side Effects
- • GIT troubles – vomiting, diarrhea
- • Hair loss
- • Risk of bleeding
- • Mouth ulcers
- • Skin rashes
- • Stomach aches
Serious Side Effects
- • Neurotoxicity: seizures, confusion
- • Ocular toxicity: dry red eyes, blurred vision
- • Bone marrow suppression: risk of bleeding
- • Hepatotoxicity: elevated liver enzymes
Precautions
To be used cautiously in patients with:
- • Pre-existing liver dysfunction
- • Renal dysfunction
- • Immune-compromised conditions
- • Neurological disorders
Contraindications
- • Known allergy or hypersensitivity to Cytarabine or any excipients
- • Breastfeeding mothers
- • Pregnant women
Warnings
To be used under the supervision of a medical practitioner or oncology specialist with adequate diagnostic and monitoring facilities.
Important Safety and Monitoring Information
Regular monitoring of blood count, hepatic and neurological assessments is recommended. Manage infection risks and assess ocular and renal functions throughout the treatment.
Storage
Store at 2–8°C and protect from light.
Administration Instructions
- • Administered intrathecal, subcutaneous, or as a slow IV infusion
- • Use immediately after reconstitution
